V

Vimian Group AB
F:0V0

Watchlist Manager
Vimian Group AB
F:0V0
Watchlist
Price: 2.66 EUR 0.95%
Market Cap: €1.4B

Wall St Price Targets

0V0 Price Targets Summary
Vimian Group AB

Wall Street analysts forecast 0V0 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 0V0 is 3.94 EUR with a low forecast of 2.72 EUR and a high forecast of 5.44 EUR.

Lowest Forecast
Price Target
2.72 EUR
2% Upside
Average Forecast
Price Target
3.94 EUR
48% Upside
Highest Forecast
Price Target
5.44 EUR
104% Upside
Vimian Group AB Competitors:
Price Targets
VRTX
Vertex Pharmaceuticals Inc
17% Upside
CNTA
Centessa Pharmaceuticals PLC
11% Upside
MRNA
Moderna Inc
-18% Downside

Revenue
Forecast

25% / Year
Past Growth
10% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
25% / Year
Past Growth
10% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 4 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 3 years is 10%.

Gross Profit
Forecast

38% / Year
Past Growth
18% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
38% / Year
Past Growth
18% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 4 years, the compound annual growth rate for Gross Profit has been 38%. The projected CAGR for the next 3 years is 18%.

Operating Income
Forecast

27% / Year
Past Growth
22% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
27% / Year
Past Growth
22% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 4 years, the compound annual growth rate for Operating Income has been 27%. The projected CAGR for the next 3 years is 22%.

Pre-Tax Income
Forecast

38% / Year
Past Growth
37% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
38% / Year
Past Growth
37% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 4 years, the compound annual growth rate for Pre-Tax Income has been 38%. The projected CAGR for the next 3 years is 37%.

Net Income
Forecast

48% / Year
Past Growth
41% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
48% / Year
Past Growth
41% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 4 years, the compound annual growth rate for Net Income has been 48%. The projected CAGR for the next 3 years is 41%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 0V0's stock price target?
Price Target
3.94 EUR

According to Wall Street analysts, the average 1-year price target for 0V0 is 3.94 EUR with a low forecast of 2.72 EUR and a high forecast of 5.44 EUR.

What is the Revenue forecast for Vimian Group AB?
Projected CAGR
10%

Over the last 4 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 3 years is 10%.

What is the Gross Profit forecast for Vimian Group AB?
Projected CAGR
18%

Over the last 4 years, the compound annual growth rate for Gross Profit has been 38%. The projected CAGR for the next 3 years is 18%.

What is the Operating Income forecast for Vimian Group AB?
Projected CAGR
22%

Over the last 4 years, the compound annual growth rate for Operating Income has been 27%. The projected CAGR for the next 3 years is 22%.

What is the Pre-Tax Income forecast for Vimian Group AB?
Projected CAGR
37%

Over the last 4 years, the compound annual growth rate for Pre-Tax Income has been 38%. The projected CAGR for the next 3 years is 37%.

What is the Net Income forecast for Vimian Group AB?
Projected CAGR
41%

Over the last 4 years, the compound annual growth rate for Net Income has been 48%. The projected CAGR for the next 3 years is 41%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett